JVLAX
Price
$25.63
Change
+$0.21 (+0.83%)
Updated
Jul 3 closing price
Net Assets
18.12B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

JVLAX vs VIVAX

Header iconJVLAX vs VIVAX Comparison
Open Charts JVLAX vs VIVAXBanner chart's image
JHancock Disciplined Value A
Price$25.63
Change+$0.21 (+0.83%)
VolumeN/A
Net Assets18.12B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
JVLAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVLAX vs. VIVAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVLAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. JVLAX (18.1B). VIVAX pays higher dividends than JVLAX: VIVAX (2.06) vs JVLAX (0.68). JVLAX was incepted earlier than VIVAX: JVLAX (17 years) vs VIVAX (33 years). JVLAX (0.97) is less costly to investors than VIVAX (0.17). JVLAX is a more actively managed with annual turnover of: 48.00 vs. VIVAX (9.00). JVLAX has a lower initial minimum investment than VIVAX: JVLAX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. JVLAX (0.65). VIVAX return over 5 years is better than : 80.14 vs. JVLAX (47.96).
JVLAXVIVAXJVLAX / VIVAX
Total Expense Ratio0.960.17565%
Annual Report Gross Expense Ratio0.970.17571%
Fund Existence17 years33 years-
Gain YTD8.2356.209133%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets18.1B189B10%
Annual Yield % from dividends0.682.0633%
Returns for 1 year0.6512.045%
Returns for 3 years18.5435.1653%
Returns for 5 years47.9680.1460%
Returns for 10 years38.33115.7433%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.